Epigenetic mechanisms of tumor resistance to immunotherapy
- 23 August 2018
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 75 (22) , 4163-4176
Abstract
The recent impact of cancer immunotherapies has firmly established the ability and importance of the immune system to fight malignancies. However, the intimate interaction between the highly dynamic tumor and immune cells leads to a selection process driven by genetic and epigenetic processes. As the molecular pathways of cancer resistance mechanisms to immunotherapy become increasingly known, novel therapeutic targets are being tested in combination with immune-stimulating approaches. We here review recent insights into the molecular mechanisms of tumor resistance with particular emphasis on epigenetic processes and place these in the context of previous models.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030-172978)
- Swiss Cancer Research grant (KFS-4136-02-2017)
- Hochspezialisierte Medizin Schwerpunkt Immunologie
- Sassella Foundation
This publication has 138 references indexed in Scilit:
- DNA Methylation and Apoptosis Resistance in Cancer CellsCells, 2013
- Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T CellsImmunity, 2011
- Inhibition of Histone Lysine Methylation Enhances Cancer–Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of CancerCancer Research, 2011
- The Polycomb complex PRC2 and its mark in lifeNature, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Epigenetic regulation of the alternatively activated macrophage phenotypeBlood, 2009
- Repression of E-cadherin by the polycomb group protein EZH2 in cancerOncogene, 2008
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008
- Epigenetic Control of the Immune Escape Mechanisms in Malignant CarcinomasMolecular and Cellular Biology, 2007
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004